Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer

Proteomics

Volumn 7, Issue 22, 2007, Pages 4192-4202

  Cui, Lunbiao ^a,b   Wang, Yubang ^a   Shi, Yuan ^a   Zhang, Zhengdong ^a   Xia, Yankai ^a   Sun, Hong ^a   Wang, Shouling ^a   Chen, Jianfeng ^a   Zhang, Wei ^c   Lu, Qiang ^c   Song, Ling ^a   Wei, Qingyi ^d   Zhang, Ruiwen ^e   Wang, Xinru ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Annexin a1; Bladder; Cancer; Expression; Protein

Indexed keywords

LIPOCORTIN 1; TEREPHTHALIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; BLADDER STONE; CANCER GRADING; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; UROTHELIUM; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANNEXIN A1; BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; CELL DIFFERENTIATION; CELL NUCLEUS; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHTHALIC ACIDS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; URINARY BLADDER CALCULI; URINARY BLADDER NEOPLASMS;

ANIMALIA; RATTUS;

EID: 36549000245     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700582     Document Type: Article

References (41)

1. Jung, I., Messing, E., Molecular mechanisms and pathways in bladder cancer development and progression. Cancer Control 2000, 7, 325-334.
2. Fukushima, S., Murai, T., Calculi, precipitates and microcrystalluria associated with irritation and cell proliferation as a mechanism of urinary bladder carcinogenesis in rats and mice. IARC Sci. Publ. 1999, 147, 159-174.
3. Shirai, T., Fukushima, S., Tagawa, Y., Okumura, M. et al., Cell proliferation induced by uracil-calculi and subsequent development of reversible papillomatosis in the rat urinary bladder. Cancer Res. 1989, 49, 378-383.
4. Clayson, D. B., Fishbein, L., Cohen, S. M., Effects of stones and other physical factors on the induction of rodent bladder cancer. Food Chem. Toxicol. 1995, 33, 771-784.
5. Kantor, A. F., Hartge, P., Hoover, R. N., Narayana, A. S. et al., Urinary tract infection and risk of bladder cancer. Am. J. Epidemiol. 1984, 119, 510-515.
6. Stonehill, W. H., Dmochowski, R. R., Patterson, A. L., Cox, C. E., Risk factors for bladder tumors in spinal cord injury patients. J. Urol. 1996, 155, 1248-1250.
7. Hess, M. J., Zhan, E. H., Foo, D. K., Yalla, S. V., Bladder cancer in patients with spinal cord injury. J. Spinal Cord Med. 2003, 26, 335-338.
8. Cui, L., Shi, Y., Qian, J., Dai, G. et al., Deregulation of the p16-cyclin D1/cyclin-dependent kinase-retinoblastoma pathway involved in the rat bladder carcinogenesis induced by terephthalic acid-calculi. Urol. Res. 2006, 34, 321-328.
9. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
10. Parente, L., Solito, E., Annexin 1: More than an anti-phospholipase protein. Inflamm. Res. 2004, 53, 125-132.
11. Schlaepfer, D. D., Haigler, H. T., Expression of Annexins as a function of cellular growth rate. J. Cell Biol. 1990, 111, 229-238.
12. Alldridge, L. C., Bryant, C. E., Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp. Cell Res. 2003, 290, 93-107.
13. Flower, R. J., Rothwell, N. J., Lipocortin-1: Cellular mechanisms and clinical relevance. Trends Pharmacol. Sci. 1994, 15, 71-76.
14. McKanna, J. A., Lipocortin 1 in apoptosis: Mammary regression. Anat. Rec. 1995, 242, 1-10.
15. Diakanova, M., Gerke, V., Ernst, J., Liautard, J. P. et al., Localization of five annexins in J774 macrophages and on isolated phagosomes. J. Cell Sci. 1997, 110, 1199-1213.
16. Traverso, V., Morris, J. F., Flower, R. J., Buckingham, J., Lipocortin 1 (annexin 1) in patches associated with the membrane of a lung adenocarcinoma cell line and in the cell cytoplasm. J. Cell Sci. 1998, 111, 1405-1418.
17. Alldridge, L. C., Harris, H. J., Plevin, R., Hannon, R., The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. J. Biol. Chem. 1999, 274, 37620-37628.
18. Solito, E., de Coupade, C., Parente, L., Flower, R. J. et al., Human annexin 1 is highly expressed during the differentiation of the human epithelial cell line A 549. Involvement of NF-IL6 in phorbol ester induction of annexin 1. Cell Growth Differ. 1998, 9, 327-336.
19. Rhee, H. J., Kim, G. Y., Huh, J. W., Kim, S. W. et al., Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur. J. Biochem. 2000, 267, 3220-3225.
20. Bai, X. F., Ni, X. G., Zhao, P., Liu, S. M. et al., Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J. Gastroenterol. 2004, 10, 1466-1470.
21. Ahn, S. H., Sawada, H., Ro, J. Y., Nicolson, G. L., Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin. Exp. Metastasis 1997, 15, 151-156.
22. Masaki, T., Tokuda, M., Ohnishi, M., Watanabe, S. et al., Enhanced expression of the protein kinase substrateannexin in human hepatocellular carcinoma. Hepatology 1996, 24, 72-81.
23. Mulla, A., Christian, H. C., Solito, E., Mendoza, N. et al., Expression, subcellular localization and phosphorylation-status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin. Endocrinol. 2004, 60, 107-119.
24. Paweletz, C. P., Ornstein, D. K., Roth, M. J., Bichsel, V. E., Loss of annexin I correlates of tumorigenesis in esophageal and prostate carcinoma. Cancer Res. 2000, 60, 6293-6297.
25. Xin, W., Rhodes, D. R., Ingold, C., Chinnaiyan, A. M. et al., Dysregulation of the annexin family protein family is associatedwith prostate cancer progression. Am. J. Pathol. 2003, 162, 255-261.
26. Vishwanatha, J. K., Salazar, E., Gopalakrishnan, V. K., Absence of annexin I expression in B-cell nonHodgkin's lymphomas and cell lines. BMC Cancer 2004, 4, 1-8.
27. Pastorelli, R., Saletta, F., Carpi, D., Campagna, R. et al., Proteome characterization of a human urothelial cell line resistant to the bladder carcinogen 4-aminobiphenyl. Proteome Sci. 2007, 5, 6.
28. Sato, E. F., Miyahara, M., Utsumi, K., Purification and characterization of a lipocortin from guinea pig neutrophils. FEBS Lett. 1988, 227, 131-135.
29. Pradel, L. A., Rendon, A., Annexin I is present in different molecular forms in rat cerebral cortex. FEBS Lett. 1993, 327, 41-44.
30. Touqui, L., Rothhut, B., Shaw, A. M., Fradin, A. et al., Platelet activation-a role for a 40K anti-phospholipase A2 protein indistinguishable from lipocortin. Nature 1986, 321, 177-180.
31. Guzman-Aranguez, A., Olmo, N., Turnay, J., Lecona, E. et al., Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. J. Cell. Biochem. 2005, 94, 178-193.
32. Huo, X. F., Zhang, J. W., Annexin1 regulates the erythroid dierentiation through ERK signaling pathway. Biochem. Biophyl. Res. Commun. 2005, 331, 1346-1352.
33. Horlick, K. R., Ganjianpour, M., Frost, S. C., Nick, H. S., Annexin-I regulation in response to suckling and rat mammary cell differentiation. Endocrinology 1990, 128, 1574-1579.
34. Violette, S. M., King, I., Browning, J. L., Pepinsky, R. B., Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma. J. Cell Physiol. 1990, 142, 70-77.
35. Garcia Pedrero, J. M., Fernandez, M. P., Morgan, R. O., Herrero Zapater, A. et al., Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am. J. Pathol. 2004, 164, 73-79.
36. Hu, N., Flaig, M. J., Su, H., Shou, J. Z. et al., Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin. Cancer Res. 2004, 10, 6013-6022.
37. Rodrigo, J. P., Garcia-Pedrero, J. M., Fernandez, M. P., Morgan, R. O. et al., Annexin A1 expression in nasopharyngeal carcinoma correlates with squamous differentiation. Am. J. Rhinol. 2005, 19, 483-487.
38. Sheng, K. H., Yao, Y. C., Chuang, S. S., Wu, H. et al., Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis. Proteomics 2006, 6, 1058-1065.
39. Sjolin, C., Stendahl, O., Dahlgren, C., Calcium-induced translocation of annexins to subcellular organelles of human neutrophils. Biochem. J. 1994, 300, 325-330.
40. Rhee, H. J., Kim, S. W., Lee, S. O., Park, Y. M. et al., Translocation of annexin I to the nucleus by epidermal growth factor in A549 cells. J. Biochem. Mol. Biol. 1999, 32, 28-32.
41. Park, H., Jang, Y. J. K., Im, D. H., Lee, S. O. et al., Transientincrease of lipocortin 1 in nuclei of the hippocampal pyramidal neurons in rats by immobilization stress. J. Biochem. Mol. Biol. 1998, 31, 117-122.